← Open Payments lookup

PATRICIA REXER: Open Payments

NPI 1518320621 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,166 in 46 payments from 13 companies in 2025. Trend: 2023 $3,639 · 2024 $3,193 · 2025 $1,166

Food & beverage: $1,160Education: $7
CompanyPaymentsAmount
GlaxoSmithKline, LLC.18$305
AstraZeneca Pharmaceuticals LP7$241
Regeneron Healthcare Solutions, Inc.4$152
GENZYME CORPORATION2$149
Takeda Pharmaceuticals U.S.A., Inc.6$128
Grifols USA, LLC1$39
ARS Pharmaceuticals Operations, Inc.2$36
Incyte Corporation1$24
Genentech USA, Inc.1$24
GC Biopharma USA, Inc.1$21

Products named: DUPIXENT, NUCALA, TRELEGY ELLIPTA, FASENRA, AIRSUPRA, CUVITRU, HYQVIA, Xembify.

Industry payments across PA — which companies pay providers there.